Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine

This publication has 25 references indexed in Scilit:

• Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice
  Vaccine, 1994
• The adjuvant effect of Vibrio cholerae and Escherichia coli heat‐labile enterotoxins is linked to their ADP‐ribosyltransferase activity
  European Journal of Immunology, 1992
• Superior cross‐protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine
  European Journal of Immunology, 1992
• The effect of cholera toxin and cholera toxin B subunit on the nasal mucosal membrane
  Vaccine, 1991
• Cross‐protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules
  European Journal of Immunology, 1991
• Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit
  Vaccine, 1989
• Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit
  Vaccine, 1988
• Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens
  Vaccine, 1988
• Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity
  European Journal of Immunology, 1984
• IMMUNITY TO INFLUENZA IN MAN
  Annual Review of Microbiology, 1983